Carlos Filinto da Silva Cais

Carlos Filinto da Silva Cais

Auto-generated profile, based on publicly available information

Carlos Filinto da Silva Cais

Department of Psychiatry, School of Medicine, State University of Campinas, Campinas, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2021 in Psychiatry Investigation
Verified
Journal Article
Open access
PDF file
HPHenrique Soares Paiva
Henrique Soares Paiva
IFIdiberto José Filho
Idiberto José Filho
CCCarlos Filinto da Silva Cais
Carlos Filinto da Silva Cais
Objective A central adrenergic hyperactivation is described in the neurobiology of posttraumatic stress disorder (PTSD) with probable variable symptomatic impact. Few studies have evaluated using the alpha-1 adrenergic antagonist prazosin for such symptoms; however, given the likely pathophysiology involved, this drug may play an important role in the pharmacological approach to PTSD.Methods This study assessed articles already published on the use of prazosin through a systematic review along a timeline in view of the symptomatic target of difficult access by standardized treatments. The impact of using this medication for the general symptoms of PTSD is also discussed. Several databases were searched for articles in the literature on the use of prazosin to treat PTSD.Results A total of 168 articles were found containing search terms in the title or Overall, 85 articles met the criteria described, and 48 studies were explored to conduct the present systematic review. Most articles showed some improvement after prazosin administration, especially in relation to sleep symptoms (nightmares and night waking). Only one article demonstrated no improvement after the use of this drug. More randomized studies are needed.Conclusion Several clinical studies demonstrated the relevant role of prazosin for treating PTSD symptoms. Prazosin is an affordable and cost-effective pharmacological option compared to other drugs used to treat PTSD.